Biphasic waveforms have been suggested as a superior waveform for ventricular defibrillation. To test this premise, a prospective randomized intraoperative evaluation of defibrillation efficacy of monophasic and biphasic waveform pulses was performed in 22 survivors of out of hospital ventricular fibrillation who were undergoing cardiac surgery for implantation of an automatic defibrillator. The initial waveform used in a patient for defibrillation testing, either monophasic or biphasic, was randomly selected. Subsequently, each patient served as his or her own control for defibrillation testing of the other waveform. The defibrillation threshold was defined as the lowest pulse amplitude that would effectively terminate ventricular fibrillation with a single discharge delivered 10 s after initiation of an episode of ventricular fibrillation induced with alternating current. Each defibrillation pulse was recorded oscilloscopically, and defibrillation pulse voltage, current, resistance and stored energy were measured. Fifteen (68%) of the 22 patients had a lower defibrillation threshold with the biphasic pulse, 3 (14%) had a lower threshold with the monophasic pulse and 4 (18%) had equal defibrillation thresholds (within 1.0 J) regardless of waveform. The mean leading edge defibrillation threshold voltage was 317 +/- 105 V when the monophasic pulse was used and 267 +/- 102 V (16% less) when the biphasic pulse was used (p = 0.008). Mean leading edge defibrillation threshold current was 7.9 +/- 3.7 A when the monophasic pulse was used and 6.8 +/- 3.8 A (14% less) when the biphasic pulse was used (p = 0.051).(ABSTRACT TRUNCATED AT 250 WORDS)

No abstract

SUMMARY As echocardiography is being used more often, its value and accuracy are becoming more fully appreciated. Coincident with wider application of this imaging technique is the potential for identifying normal anatomic variants and their possible erroneous interpretation as pathologic states. In this report we describe the M-mode and two-dimensional echocardiographic features of a congenital remnant known as the Chiari network. This structure can present as a highly mobile, highly reflectant echo target that can be seen in several locations in the right atrium. We report here an index case that could be well examined echocardiographically and that was a cause of considerable concern due to the presence of congestive heart failure and a history of staphylococcal endocarditis. The presence of the Chiari network was confirmed pathologically. Subsequently, we found similar echocardiographic findings in 19 of 1248 patients (1.5%) studied in our laboratory. This congenital remnant, which is found pathologically in 2-3% of normal hearts, could be confused with valve disruption, vegetation or other mass lesion, particularly when associated with a suggestive clinical situation.M-MODE and two-dimensional echocardiography have gained wide acceptance for providing safe, repeatable and accurate diagnostic information in a variety of complicated clinical situations. Suspicion of valvular heart disease, particularly infection of the valves, represents an important indication for echocardiographic examination.1 2 Increasing experience with these techniques has allowed a better, and in some cases new, appreciation of normal and abnormal cardiac anatomy, motion and structural relationships.3 These include structures often described at cardiac surgery or at postmortem examination, but not previously demonstrable in ambulatory patients. We describe the echocardiographic appearance of the Chiari network, a not uncommon anatomic finding that might be considered a "normal variant."4 This structure, particularly in the setting of fever, congestive heart failure, pulmonary infiltrates and a history of i.v. drug abuse, could be mistaken for evidence of active infection or disruption of normal right-sided structures, possibly requiring urgent cardiac surgery. Materials

No abstract

Background-The first Björk-Shiley convexoconcave (BSCC) prosthetic heart valves were implanted in 1978. The 25th anniversary provided a stimulus to summarize the research data relevant to BSCC valve fracture, patient management, and current clinical options.